Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia
- 1 December 1989
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 103 (3) , 625-632
- https://doi.org/10.1017/s0950268800031022
Abstract
The cell-mediated immune response (CMI) to E6 and E4 fusion proteins of human papillomavirus type 16 (HPV-16), E6 fusion protein of HPV-18, and to control proteins similarly produced, was analysed in 29 patients with cervical intraepithelial neoplasia (CIN) and in 15 age-matched laboratory personnel using a lymphocyte proliferation assay (LPA).This publication has 39 references indexed in Scilit:
- Expression of human papillomavirus types 16 and 18 DNA sequences in cervical carcinoma cell linesJournal of Medical Virology, 1988
- Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.Journal of Clinical Pathology, 1988
- Humoral and cellular immunity to papillomavirus in patients with cervical dysplasiaJournal of Medical Virology, 1988
- A Murine Model of Herpes Simplex Virus RecrudescenceJournal of General Virology, 1987
- Identification of Human Papillomavirus Type 18 E6 Polypeptide in Cells Derived from Human Cervical CarcinomasJournal of General Virology, 1987
- Integration and Transcription of Human Papillomavirus Type 16 and 18 Sequences in Cell Lines Derived from Cervical CarcinomasJournal of General Virology, 1987
- Human papillomavirus infections in a group of renal transplant recipientsBritish Journal of Dermatology, 1986
- The Expression of Human Papillomavirus Type 18 E6 Protein in Bacteria and the Production of Anti-E6 AntibodiesJournal of General Virology, 1986
- Specificity of cytopathic effect of cutaneous human papillomavirusesClinics in Dermatology, 1985
- In vitro lymphocyte stimulation by wart antigen in manBritish Journal of Dermatology, 1976